| 1 | BCL3, TNFSF11, TRAF6
|
| BCL3 regulates RANKL-induced osteoclastogenesis by interacting with TRAF6 in bone marrow-derived macrophages.
|
| Wang K, Li S, Gao Y, Feng X, Liu W, Luo R, Song Y, Ji Tu, Liu Y, Yang C
|
| Bone. Sep;114:257-267. doi: 10.1016/j.bone.2018.06.015. Epub 2018 Jun 19. 2018
|
| 2 | EPX, MPO, TNFSF11
|
| Peroxidase enzymes inhibit osteoclast differentiation and bone resorption.
|
| Panagopoulos V, Liapis V, Zinonos I, Hay S, Leach DA, Ingman W, DeNichilo MO, Atkins GJ, Findlay DM, Zannettino ACW, Evdokiou A.
|
| Mol Cell Endocrinol 440:8-15. doi: 10.1016/j.mce.2016.11.007. Epub 2016 Nov 9.
2017
|
| 3 | TNFRSF11A, TNFSF11
|
| Novel RANKL DE-loop mutants antagonize RANK-mediated osteoclastogenesis.
|
| Wang Y, van Assen AHG, Reis CR, Setroikromo R, van Merkerk R, Boersma YL, Cool RH, Quax WJ.
|
| FEBS J 284(15):2501-2512. doi: 10.1111/febs.14142. Epub 2017 Jul 7.
2017
|
| 4 | TNFRSF11A, TNFSF11
|
| Up-Regulation of RANK Expression via ERK1/2 by Insulin Contributes to the Enhancement of Osteoclast Differentiation.
|
| Oh JH, Lee NK.
|
| Mol Cells 40(5):371-377. doi: 10.14348/molcells.2017.0025. Epub 2017 May 22.
2017
|
| 5 | PTGS2, PTH, TNFSF11
|
| Prostaglandin-mediated inhibition of PTH-stimulated β-catenin signaling in osteoblasts by bone marrow macrophages.
|
| Estus TL, Choudhary S, Pilbeam CC.
|
| Bone 85:123-30. doi: 10.1016/j.bone.2016.01.023.
2016
|
| 6 | LDHA, LDHB, NFATC1, TNFSF11
|
| Accelerated Lactate Dehydrogenase Activity Potentiates Osteoclastogenesis via NFATc1 Signaling.
|
| Ahn H, Lee K, Kim JM, Kwon SH, Lee SH, Lee SY, Jeong D.
|
| PLoS One 11(4):e0153886. doi: 10.1371/journal.pone.0153886. eCollection 2016.
2016
|
| 7 | TNFSF11
|
| Involvement of the G-protein-coupled receptor 4 in RANKL expression by osteoblasts in an acidic environment.
|
| Okito A, Nakahama K, Akiyama M, Ono T, Morita I.
|
| Biochem Biophys Res Commun 458(2):435-40. doi: 10.1016/j.bbrc.2015.01.142.
2015
|
| 8 | TNFRSF11A, TNFRSF11B, TNFSF11
|
| Expression of osteoprotegerin, RNAK and RANKL genes in femoral head avascular necrosis and related signaling pathway.
|
| Miao Q, Hao S, Li H, Sun F, Wang X.
|
| Int J Clin Exp Pathol 8(9):10460-7. eCollection 2015.
2015
|
| 9 | TNFRSF11A, TNFRSF11B, TNFSF11
|
| Regulation of Osteoblast Migration Involving Receptor Activator of Nuclear Factor-kappa B (RANK) Signaling.
|
| Golden D, Saria EA, Hansen MF.
|
| J Cell Physiol 230(12):2951-60. doi: 10.1002/jcp.25024.
2015
|
| 10 | TNFRSF11A, TNFSF11
|
| Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function.
|
| Warren JT, Zou W, Decker CE, Rohatgi N, Nelson CA, Fremont DH, Teitelbaum SL.
|
| J Cell Biochem 116(11):2476-83. doi: 10.1002/jcb.25191.
2015
|
| 11 | CTGF, TNFRSF11A, TNFRSF11B, TNFSF11
|
| CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG.
|
| Aoyama E, Kubota S, Khattab HM, Nishida T, Takigawa M.
|
| Bone 73:242-8. doi: 10.1016/j.bone.2014.12.058. Epub 2014 Dec 30.
2015
|
| 12 | NRROS, TNFSF11
|
| NRROS Negatively Regulates Osteoclast Differentiation by Inhibiting RANKL-Mediated NF-N:B and Reactive Oxygen Species Pathways.
|
| Kim JH, Kim K, Kim I, Seong S, Kim N.
|
| Mol Cells. Oct;38(10):904-10. doi: 10.14348/molcells.2015.0177. Epub 2015 Oct 7 2015
|
| 13 | ARL6IP5, TNFSF11
|
| Overexpression of Arl6ip5 in osteoblast regulates RANKL subcellualr localization.
|
| Wu Y, Wang M, Peng Y, Ding Y, Deng L, Fu Q.
|
| Biochem Biophys Res Commun. Sep 4;464(4):1275-1281. doi: 10.1016/j.bbrc.2015.07.119. Epub 2015 Jul 26. 2015
|
| 14 | TNFRSF11A, TNFRSF11B, TNFSF11
|
| Potential role of the OPG/RANK/RANKL axis in prostate cancer invasion and bone metastasis.
|
| Li X, Liu Y, Wu B, Dong Z, Wang Y, Lu J, Shi P, Bai W, Wang Z.
|
| Oncol Rep 32(6):2605-11. doi: 10.3892/or.2014.3511. Epub 2014 Sep 23.
2014
|
| 15 | TNFRSF11A, TNFSF11
|
| RANK receptor oligomerisation in the regulation of NFκB signalling.
|
| Das S, Sepahi I, Duthie A, Clark S, Crockett JC.
|
| J Mol Endocrinol 53(1):81-91. doi: 10.1530/JME-14-0077. Epub 2014 May 23.
2014
|
| 16 | TNFRSF11A, TNFRSF11B, TNFSF11
|
| Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis.
|
| Samara S, Dailiana Z, Chassanidis C, Koromila T, Papatheodorou L, Malizos KN, Kollia P.
|
| Exp Mol Pathol 96(1):9-14. doi: 10.1016/j.yexmp.2013.10.014. Epub 2013 Nov 5.
2014
|
| 17 | PGR, STAT5A, TNFSF11
|
| Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells.
|
| Obr AE, Grimm SL, Bishop KA, Pike JW, Lydon JP, Edwards DP.
|
| Mol Endocrinol 27(11):1808-24. doi: 10.1210/me.2013-1077. Epub 2013 Sep 6.
2013
|
| 18 | PIP5K1C, TNFSF11
|
| Type I phosphotidylinosotol 4-phosphate 5-kinase γ regulates osteoclasts in a bifunctional manner.
|
| Zhu T, Chappel JC, Hsu FF, Turk J, Aurora R, Hyrc K, De Camilli P, Broekelmann TJ, Mecham RP, Teitelbaum SL, Zou W.
|
| J Biol Chem 288(8):5268-77. doi: 10.1074/jbc.M112.446054. Epub 2013 Jan 7.
2013
|
| 19 | HDAC7, NFATC2, TNFSF11
|
| HDAC7 inhibits osteoclastogenesis by reversing RANKL-triggered β-catenin switch.
|
| Jin Z, Wei W, Dechow PC, Wan Y.
|
| Mol Endocrinol 27(2):325-35. doi: 10.1210/me.2012-1302. Epub 2012 Nov 30.
2013
|
| 20 | MAP3K7, TNFSF11
|
| TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis.
|
| Lamothe B, Lai Y, Xie M, Schneider MD, Darnay BG.
|
| Mol Cell Biol 33(3):582-95. doi: 10.1128/MCB.01225-12. Epub 2012 Nov 19.
2013
|
| 21 | SIGLEC15, TNFSF11
|
| Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.
|
| Kameda Y, Takahata M, Komatsu M, Mikuni S, Hatakeyama S, Shimizu T, Angata T, Kinjo M, Minami A, Iwasaki N.
|
| J Bone Miner Res 28(12):2463-75. doi: 10.1002/jbmr.1989.
2013
|
| 22 | TNFRSF11A, TNFSF11
|
| Inhibition effect of enteropeptidase on RANKL-RANK signalling by cleavage of RANK.
|
| Zhao Y, Jin M, Ma J, Zhang S, Li W, Chen Y, Zhou Y, Tao H, Liu Y, Wang L, Han H, Niu G, Tao H, Liu C, Gao B.
|
| FEBS Lett 587(18):2958-64. doi: 10.1016/j.febslet.2013.08.005. Epub 2013 Aug 13.
2013
|
| 23 | EGR2, TNFSF11
|
| Early growth response 2 negatively modulates osteoclast differentiation through upregulation of Id helix-loop-helix proteins.
|
| Kim HJ, Hong JM, Yoon KA, Kim N, Cho DW, Choi JY, Lee IK, Kim SY.
|
| Bone 51(4):643-50. doi: 10.1016/j.bone.2012.07.015. Epub 2012 Jul 26.
2012
|
| 24 | OPTB2, TNFSF11
|
| A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF.
|
| Douni E, Rinotas V, Makrinou E, Zwerina J, Penninger JM, Eliopoulos E, Schett G, Kollias G.
|
| Hum Mol Genet 21(4):784-98. doi: 10.1093/hmg/ddr510. Epub 2011 Nov 7.
2012
|
| 25 | ADORA1, TNFSF11
|
| Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling.
|
| He W, Cronstein BN.
|
| Purinergic Signal 8(2):327-37. doi: 10.1007/s11302-012-9292-9. Epub 2012 Feb 5.
2012
|
| 26 | LAT, TNFSF11
|
| The transmembrane adaptor protein, linker for activation of T cells (LAT), regulates RANKL-induced osteoclast differentiation.
|
| Kim K, Kim JH, Moon JB, Lee J, Kwak HB, Park YW, Kim N.
|
| Mol Cells 33(4):401-6. doi: 10.1007/s10059-012-0009-2. Epub 2012 Feb 28.
2012
|
| 27 | ICAM1, TNFSF11
|
| RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation.
|
| Chen LM, Kuo CH, Lai TY, Lin YM, Su CC, Hsu HH, Tsai FJ, Tsai CH, Huang CY, Tang CH.
|
| J Cell Biochem 112(3):933-41. doi: 10.1002/jcb.23009.
2011
|
| 28 | NFATC1, TNFSF11
|
| NFATC1 promotes epicardium-derived cell invasion into myocardium.
|
| Combs MD, Braitsch CM, Lange AW, James JF, Yutzey KE.
|
| Development 138(9):1747-57. Epub 2011 Mar 29.
2011
|
| 29 | ACP5, NFATC1, OSCAR, TNFSF11
|
| RANKL induces NFATc1 acetylation and stability via histone acetyltransferases during osteoclast differentiation.
|
| Kim JH, Kim K, Youn BU, Jin HM, Kim JY, Moon JB, Ko A, Seo SB, Lee KY, Kim N.
|
| Biochem J 436(2):253-62.
2011
|
| 30 | TNFRSF11B, TNFSF11
|
| Expression of RANKL/OPG during bone remodeling in vivo.
|
| Tanaka H, Mine T, Ogasa H, Taguchi T, Liang CT.
|
| Biochem Biophys Res Commun. 411(4):690-4. 2011
|
| 31 | TNFSF11
|
| Evidence for osteocyte regulation of bone homeostasis through RANKL expression.
|
| Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, Penninger JM, Takayanagi H.
|
| Nat Med 17(10):1231-4. doi: 10.1038/nm.2452.
2011
|
| 32 | RAB27A, RAB27B, TNFSF11
|
| Rab27a and Rab27b are involved in stimulation-dependent RANKL release from secretory lysosomes in osteoblastic cells.
|
| Kariya Y, Honma M, Hanamura A, Aoki S, Ninomiya T, Nakamichi Y, Udagawa N, Suzuki H.
|
| J Bone Miner Res 26(4):689-703. doi: 10.1002/jbmr.268.
2011
|
| 33 | IL4, TNFSF11
|
| Interleukin-4 inhibits RANKL-induced NFATc1 expression via STAT6: a novel mechanism mediating its blockade of osteoclastogenesis.
|
| Cheng J, Liu J, Shi Z, Xu D, Luo S, Siegal GP, Feng X, Wei S.
|
| J Cell Biochem 112(11):3385-92. doi: 10.1002/jcb.23269.
2011
|
| 34 | SERPINF1, TNFSF11
|
| PEDF regulates osteoclasts via osteoprotegerin and RANKL.
|
| Akiyama T, Dass CR, Shinoda Y, Kawano H, Tanaka S, Choong PF.
|
| Biochem Biophys Res Commun 391(1):789-94. Epub 2009 Nov 27.PMID: 19945427 2010
|
| 35 | ESR1, ESR2, LRP4, LRP5, SOST, TNFRSF11A, TNFRSF11B, TNFSF11, VDR, WLS
|
| Genetics of osteoporosis: accelerating pace in gene identification and validation.
|
| Li WF, Hou SX, Yu B, Li MM, Férec C, Chen JM.
|
| Hum Genet 127(3):249-85. Epub 2009 Dec 12. Review.PMID: 20101412 2010
|
| 36 | TNFSF11
|
| Camurati-engelmann disease: Unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand.
|
| Whyte MP, Totty WG, Novack DV, Zhang X, Wenkert D, Mumm S.
|
| J Bone Miner Res Bone Miner Res. 2010 Nov 4. [Epub ahead of print]PMID: 21053311 2010
|
| 37 | TNFRSF11A, TNFSF11
|
| Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases.
|
| Santini D, Perrone G, Roato I, Godio L, Pantano F, Grasso D, Russo A, Vincenzi B, Elisabetta Fratto M, Sabbatini R, Pepa CD, Porta C, Del Greco A, Schiavon G, Berruti A, Tomasino RM, Papotti M, Papapietro N, Onetti Muda A, Denaro V, Tonini G.
|
| J Cell Physiol Cell Physiol. 2010 Sep 20. [Epub ahead of print]PMID: 20857484 2010
|
| 38 | TNFSF11
|
| Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.
|
| Schramek D, Leibbrandt A, Sigl V, Kenner L, Pospisilik JA, Lee HJ, Hanada R, Joshi PA, Aliprantis A, Glimcher L, Pasparakis M, Khokha R, Ormandy CJ, Widschwendter M, Schett G, Penninger JM.
|
| Nature. 468(7320):98-102. 2010
|
| 39 | TNFSF11
|
| RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.
|
| Gonzalez-Suarez E, Jacob AP, Jones J, Miller R, Roudier-Meyer MP, Erwert R, Pinkas J, Branstetter D, Dougall WC.
|
| Nature. 468(7320):103-7. 2010
|
| 40 | CKB, PARP1, TNFSF11
|
| RANKL up-regulates brain-type creatine kinase via poly(ADP-ribose) polymerase-1 during osteoclastogenesis.
|
| Chen J, Sun Y, Mao X, Liu Q, Wu H, Chen Y.
|
| J Biol Chem 285(47):36315-21. Epub 2010 Sep 13.
2010
|
| 41 | CARD9, DNMT3A, ERAP2, FUT2, PTGER4, TNFSF11
|
| Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.
|
| Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, Lees CW, Balschun T, Lee J, Roberts R, Anderson CA, Bis JC, Bumpstead S, Ellinghaus D, Festen EM, Georges M, Green T, Haritunians T, Jostins L, Latiano A, Mathew CG, Montgomery GW, Prescott NJ, Raychaudhuri S, Rotter JI, Schumm P, Sharma Y, Simms LA, Taylor KD, Whiteman D, Wijmenga C, Baldassano RN, Barclay M, Bayless TM, Brand S, Büning C, Cohen A, Colombel JF, Cottone M, Stronati L, Denson T, De Vos M, D'Inca R, Dubinsky M, Edwards C, Florin T, Franchimont D, Gearry R, Glas J, Van Gossum A, Guthery SL, Halfvarson J, Verspaget HW, Hugot JP, Karban A, Laukens D, Lawrance I, Lemann M, Levine A, Libioulle C, Louis E, Mowat C, Newman W, Panés J, Phillips A, Proctor DD, Regueiro M, Russell R, Rutgeerts P, Sanderson J, Sans M, Seibold F, Steinhart AH, Stokkers PC, Torkvist L, Kullak-Ublick G, Wilson D, Walters T, Targan SR, Brant SR, Rioux JD, D'Amato M, Weersma RK, Kugathasan S, Griffiths AM, Mansfield JC, Vermeire S, Duerr RH, Silverberg MS, Satsangi J, Schreiber S, Cho JH, Annese V, Hakonarson H, Daly MJ, Parkes M.
|
| Nat Genet 42(12):1118-25.
2010
|
| 42 | TNFRSF11A, TNFSF11, XPR1
|
| RANKL-RANK signaling regulates expression of xenotropic and polytropic virus receptor (XPR1) in osteoclasts.
|
| Sharma P, Patntirapong S, Hann S, Hauschka PV.
|
| Biochem Biophys Res Commun. Aug 20;399(2):129-32. doi: 10.1016/j.bbrc.2010.07.022. Epub 2010 Jul 13 2010
|
| 43 | CTSK, NFATC1, TNFSF11
|
| Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
|
| Balkan W, Martinez AF, Fernandez I, Rodriguez MA, Pang M, Troen BR.
|
| Gene 446(2):90-8. Epub 2009 Jun 27.
2009
|
| 44 | TNFSF11
|
| Central control of fever and female body temperature by RANKL/RANK.
|
| Hanada R, Leibbrandt A, Hanada T, Kitaoka S, Furuyashiki T, Fujihara H, Trichereau J, Paolino M, Qadri F, Plehm R, Klaere S, Komnenovic V, Mimata H, Yoshimatsu H, Takahashi N, von Haeseler A, Bader M, Kilic SS, Ueta Y, Pifl C, Narumiya S, Penninger JM.
|
| Nature. 462(7272):505-9. 2009
|
| 45 | E2F1, TNFSF11
|
| Transcriptional regulation of human RANK ligand gene expression by E2F1.
|
| Hu Y, Sun M, Nadiminty N, Lou W, Pinder E, Gao AC.
|
| Biochem Biophys Res Commun 370(3):440-4. Epub 2008 Mar 31. 2008
|
| 46 | TNFSF11, VEGFC
|
| VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism.
|
| Zhang Q, Guo R, Lu Y, Zhao L, Zhou Q, Schwarz EM, Huang J, Chen D, Jin ZG, Boyce BF, Xing L.
|
| J Biol Chem 283(19):13491-9. Epub 2008 Mar 20. 2008
|
| 47 | OSCAR, TNFSF11, USF1, USF2
|
| Upstream stimulatory factors regulate OSCAR gene expression in RANKL-mediated osteoclast differentiation.
|
| Kim JH, Kim K, Jin HM, Youn BU, Song I, Choi HS, Kim N.
|
| J Mol Biol 383(3):502-11. Epub 2008 Aug 22.PMID: 18762192 2008
|
| 48 | TNFRSF11A, TNFSF11
|
| Functions of RANKL/RANK/OPG in bone modeling and remodeling.
|
| Boyce BF, Xing L.
|
| Arch Biochem Biophys 473(2):139-46. Epub 2008 Mar 25. Review.PMID: 18395508 2008
|
| 49 | CALCA, CALCRL, TNFSF11
|
| Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation.
|
| Granholm S, Lundberg P, Lerner UH.
|
| J Cell Biochem 104(3):920-33. doi: 10.1002/jcb.21674.
2008
|
| 50 | GPR68, NFATC1, RGS18, TNFSF11
|
| RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
|
| Iwai K, Koike M, Ohshima S, Miyatake K, Uchiyama Y, Saeki Y, Ishii M.
|
| J Bone Miner Res 22(10):1612-20. 2007
|
| 51 | TNFSF11,TRAF6
|
| TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation.
|
| Lamothe B, Webster WK, Gopinathan A, Besse A, Campos AD, Darnay BG.
|
| Biochem Biophys Res Commun 359(4):1044-9. Epub 2007 Jun 11. 2007
|
| 52 | OPTB2, TNFSF11
|
| Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL.
|
| Sobacchi C, Frattini A, Guerrini MM, Abinun M, Pangrazio A, Susani L, Bredius R, Mancini G, Cant A, Bishop N, Grabowski P, Del Fattore A, Messina C, Errigo G, Coxon FP, Scott DI, Teti A, Rogers MJ, Vezzoni P, Villa A, Helfrich MH.
|
| Nat Genet 39(8):960-2. Epub 2007 Jul 15. 2007
|
| 53 | CCL20, CCR6, TNFSF11
|
| CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients.
|
| Lisignoli G, Piacentini A, Cristino S, Grassi F, Cavallo C, Cattini L, Tonnarelli B, Manferdini C, Facchini A.
|
| J Cell Physiol 210(3):798-806.
2007
|
| 54 | TNFRSF11A, TNFRSF11B, TNFSF11
|
| Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells.
|
| Mori K, Berreur M, Blanchard F, Chevalier C, Guisle-Marsollier I, Masson M, Rédini F, Heymann D.
|
| Oncol Rep 18(6):1365-71.
2007
|
| 55 | TNFRSF11B, TNFSF11, TNFRSF11A
|
| Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men.
|
| Hsu YH, Niu T, Terwedow HA, Xu X, Feng Y, Li Z, Brain JD, Rosen CJ, Laird N, Xu X.
|
| Hum Genet 118(5):568-77. Epub 2005 Oct 26. 2006
|
| 56 | TNFSF11
|
| Regulation of cancer cell migration and bone metastasis by RANKL.
|
| Jones DH, Nakashima T, Sanchez OH, Kozieradzki I, Komarova SV, Sarosi I, Morony S, Rubin E, Sarao R, Hojilla CV, Komnenovic V, Kong YY, Schreiber M, Dixon SJ, Sims SM, Khokha R, Wada T, Penninger JM.
|
| Nature 440(7084):692-6. 2006
|
| 57 | TNFSF11, TNFRSF11A
|
| Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells.
|
| Loser K, Mehling A, Loeser S, Apelt J, Kuhn A, Grabbe S, Schwarz T, Penninger JM, Beissert S.
|
| Nat Med 12(12):1372-9. Epub 2006 Dec 3. 2006
|
| 58 | NFATC1, TNFSF11, CTSK
|
| NFATc1 expression in the developing heart valves is responsive to the RANKL pathway and is required for endocardial expression of cathepsin K.
|
| Lange AW, Yutzey KE.
|
| Dev Biol 292(2):407-17. 2006
|
| 59 | TNFSF11, NFATC1
|
| RANK-L induces the expression of NFATc1, but not of NFkappaB subunits during osteoclast formation.
|
| Zhu LL, Zaidi S, Moonga BS, Troen BR, Sun L.
|
| Biochem Biophys Res Commun 326(1):131-5. 2005
|
| 60 | ANXA2,TNFSF11
|
| Annexin II stimulates RANKL expression through MAPK.
|
| Li F, Chung H, Reddy SV, Lu G, Kurihara N, Zhao AZ, Roodman GD.
|
| J Bone Miner Res 20(7):1161-7. Epub 2005 Feb 14. 2005
|
| 61 | RASA4, TNFSF11
|
| Identification of an alternatively spliced variant of Ca2+-promoted Ras inactivator as a possible regulator of RANKL shedding.
|
| Hikita A, Kadono Y, Chikuda H, Fukuda A, Wakeyama H, Yasuda H, Nakamura K, Oda H, Miyazaki T, Tanaka S.
|
| J Biol Chem 280(50):41700-6. Epub 2005 Oct 18. 2005
|
| 62 | TNFSF11, TNFRSF11B
|
| The RANKL/OPG system and bone mineral density in patients with chronic liver disease.
|
| Moschen AR, Kaser A, Stadlmann S, Millonig G, Kaser S, Muhllechner P, Habior A, Graziadei I, Vogel W, Tilg H.
|
| J Hepatol 43(6):973-83. Epub 2005 Jul 5. 2005
|
| 63 | TNFSF11
|
|
|
| Lynch CC, Hikosaka A, Acuff HB, Martin MD, Kawai N, Singh RK, Vargo-Gogola TC, Begtrup JL, Peterson TE, Fingleton B, Shirai T, Matrisian LM, Futakuchi M.
|
| Cancer Res. 7(5):485-96. 2005
|
| 64 | TNFSF11, TYROBP, CSF1, OSCAR
|
| Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.
|
| Koga T, Inui M, Inoue K, Kim S, Suematsu A, Kobayashi E, Iwata T, Ohnishi H, Matozaki T, Kodama T, Taniguchi T, Takayanagi H, Takai T.
|
| Nature 428(6984):758-63. 2004
|
| 65 | TNFSF11
|
| Expression and function of RANK in human monocyte chemotaxis.
|
| Mosheimer BA, Kaneider NC, Feistritzer C, Sturn DH, Wiedermann CJ.
|
| Arthritis Rheum. 50(7):2309-16. 2004
|
| 66 | TNFSF11
|
| RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta.
|
| Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, Yokochi T, Oda H, Nakamura K, Ida N, Wagner EF, Taniguchi T.
|
| Nature 416(6882):744-9. 2002
|
| 67 | TNFSF11, CALCA, TNFRSF11B
|
| Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
|
| Kudo O, Sabokbar A, Pocock A, Itonaga I, Athanasou NA.
|
| Calcif Tissue Int 71(6):539-46. Epub 2002 Sep 18. 2002
|
| 68 | TNFSF11
|
| RANKL induces formation of avian osteoclasts from macrophages but not from macrophage polykaryons.
|
| Boissy P, Destaing O, Jurdic P.
|
| Biochem Biophys Res Commun 288(2):340-6. 2001
|
| 69 | TNFSF11
|
| The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development.
|
| Fata JE, Kong YY, Li J, Sasaki T, Irie-Sasaki J, Moorehead RA, Elliott R, Scully S, Voura EB, Lacey DL, Boyle WJ, Khokha R, Penninger JM.
|
| Cell 103(1):41-50. 2000
|
| 70 | TNFSF11
|
| Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF/TRANCE that induces osteoclast formation.
|
| Nagai M, Kyakumoto S, Sato N.
|
| Biochem Biophys Res Commun 269(2):532-6. 2000
|
| 71 | FOS, FOSL1, TNFSF11
|
| Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation.
|
| Matsuo K, Owens JM, Tonko M, Elliott C, Chambers TJ, Wagner EF.
|
| Nat Genet 24(2):184-7. 2000
|
| 72 | TNFSF11
|
| Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene.
|
| Kim N, Odgren PR, Kim DK, Marks SC Jr, Choi Y.
|
| Proc Natl Acad Sci U S A. 97(20):10905-10. 2000
|
| 73 | TNFSF11
|
| Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion.
|
| Wani MR, et al.
|
| Endocrinology 140(4):1927-35. 1999
|
| 74 | TNFSF11
|
| A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
|
| Takahashi N, et al.
|
| Biochem Biophys Res Commun 256(3):449-55. 1999
|
| 75 | IL1B, TNFRSF11B, TNFSF11
|
| Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells.
|
| Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S.
|
| Bone 25(3):255-9 1999
|
| 76 | SRC, TNFSF11, TRAF6
|
| TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src.
|
| Wong BR, Besser D, Kim N, Arron JR, Vologodskaia M, Hanafusa H, Choi Y.
|
| Mol Cell 4(6):1041-9 1999
|
| 77 | TNFSF11
|
| Localization of RANKL (receptor activator of NFkappaB ligand) mRNA and protein in skeletal and extraskeletal tissues.
|
| Kartsogiannis V, Zhou H, Horwood NJ, Thomas RJ, Hards DK, Quinn JM, Niforas P, Ng KW, Martin TJ, Gillespie MT.
|
| Bone 25(5):525-34 1999
|
| 78 | TNFSF11
|
| Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.
|
| Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM.
|
| Nature 402(6759):304-9 1999
|
| 79 | TNFSF11
|
| Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
|
| Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ.
|
| Cell 93(2):165-76 1998
|
| 80 | TNFRSF11B, TNFSF11
|
| Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.
|
| Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T.
|
| Proc Natl Acad Sci U S A. 95(7):3597-602. 1998
|
| 81 | TNFRSF11A, TNFSF11
|
| A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
|
| Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L.
|
| Nature 390(6656):175-9. 1997
|
| 82 | TNFSF11
|
| TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells.
|
| Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett FS 3rd, Frankel WN, Lee SY, Choi Y.
|
| J Biol Chem 272(40):25190-4. 1997
|